Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...
LifeStance Health reports that 73% of patients see significant improvement in depression and 79% in anxiety after treatment, ...
A new Cochrane review confirmed that antidepressants, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs), are superior to placebo in ...
A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months. The study involved 198 adults with generalized anxiety disorder, or GAD, a disabling form of anxiety ...
NEW YORK, March 5, 2026 /PRNewswire/ -- Market News Updates News Commentary - Treatments for Generalized Anxiety Disorder (GAD) are getting better and more accessible, which is good news for millions ...
The retrospective analysis examined de-identified data from 3,604 episodes of care between January 1, 2023, and December 31, 2025. Results showed that patients experienced substantial and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results